Atlanta, GA, United States of America

Marion Koopmans

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marion Koopmans: Innovator in Viral Research

Introduction

Marion Koopmans is a prominent inventor based in Atlanta, GA (US). She has made significant contributions to the field of virology, particularly in the study of human astroviruses. Her work has implications for understanding viral infections and developing diagnostic tools.

Latest Patents

Koopmans holds a patent for "Nucleic acids encoding human astrovirus serotype 2." This invention provides a nucleic acid encoding human astrovirus serotype 2, or a unique fragment thereof. The sequence, a genomic RNA of human astrovirus serotype 2, contains 6,797 nucleotides and is organized into three open reading frames. Additionally, the patent includes purified antigenic polypeptide fragments encoded by the nucleic acid, as well as a monoclonal antibody specific for human astrovirus serotype 2. The invention also outlines methods for detecting the presence of serotype 2 utilizing these products.

Career Highlights

Throughout her career, Marion Koopmans has been recognized for her innovative research and contributions to the scientific community. Her work has advanced the understanding of viral pathogens and their impact on human health.

Collaborations

Koopmans has collaborated with notable colleagues, including Baoming Jiang and Roger I Glass. These partnerships have further enriched her research and expanded the scope of her work in virology.

Conclusion

Marion Koopmans is a trailblazer in the field of viral research, with a focus on human astroviruses. Her patent and collaborative efforts highlight her commitment to advancing scientific knowledge and improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…